Streetbeat News

Analyst Ratings

LLY

Unusual options activity has been observed for Eli Lilly (NYSE:LLY), with a bearish stance taken by a large investor. The sentiment among these big-money traders is split between 13% bullish and 86% bearish. The whales have been targeting a price range from $340.0 to $660.0 for Eli Lilly over the last 3 months. Cantor Fitzgerald has downgraded its action to Overweight with a price target of $485 and maintained their Overweight rating with a price target of $550. Truist Securities downgraded its action to Buy with a price target of $430.

Portfolio Pulse from Benzinga Insights

July 10, 2023 | 4:33 pm

DAL

UAL

United Airlines Holdings Inc (UAL) shares are trading higher by 1.64% to $56.30 after Citigroup analyst Stephen Trent maintained the stock with a Buy and raised the price target from $70 to $75. UAL shares are also higher by 9.7% over the trailing month amid strength in travel stocks, following May CPI data. Airline stocks also saw strength in late June in sympathy with Delta Air Lines, Inc. (DAL) after the company raised its second-quarter and 2023 guidance at its Investor Day presentation.

Portfolio Pulse from Henry Khederian

July 10, 2023 | 4:29 pm

BTCUSD

ETHUSD

Vitalik Buterin, co-founder of Ethereum, suggested that Bitcoin needs to adopt scalable solutions like Ethereum to expand beyond just a payment system. He mentioned Optimism and Arbitrum as two prominent rollup examples that Bitcoin could learn from. Ethereum has transitioned from a proof-of-work to a proof-of-stake network, while experimenting with various Layer 2 solutions such as ZK-rollups and Plasma. Bitcoin's scalability has been improved by the Lightning Network and the advent of Bitcoin Ordinals.

Portfolio Pulse from Murtuza Merchant

July 10, 2023 | 4:29 pm

CLSD

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Clearside Biomedical (NASDAQ:CLSD) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 4:17 pm

KTTA

EF Hutton analyst Elemer Piros has reiterated a 'Buy' rating on Pasithea Therapeutics (NASDAQ:KTTA) and maintained a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 4:15 pm

SPGI

Over the past 3 months, 8 analysts have published their opinion on S&P Global (NYSE:SPGI) stock. The company has an average price target of $421.25, an increase of 4.84% from the previous average price target of $401.80. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 10, 2023 | 4:01 pm

NAVI

Navient (NASDAQ:NAVI) has received 4 indifferent and 1 somewhat bearish analyst ratings in the last quarter. The average price target is $17.7, which is lower than the current price of $18.39, implying a downside. This average has decreased by 1.67% from the previous average price target of $18.00.

Portfolio Pulse from Benzinga Insights

July 10, 2023 | 4:01 pm

SWK

Stanley Black & Decker (NYSE:SWK) has received indifferent ratings from seven analysts in the last quarter. The average 12-month price target for the company, according to these analysts, is $90.43, a decrease of 6.77% from the previous average price target of $97.00.

Portfolio Pulse from Benzinga Insights

July 10, 2023 | 4:00 pm

ATLX

EF Hutton analyst Chip Moore assumes Atlas Lithium (NASDAQ:ATLX) with a Buy rating and announces a price target of $48.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 3:58 pm

EBAY

Wells Fargo analyst Ken Gawrelski has maintained an Equal-Weight rating on eBay (NASDAQ:EBAY) and raised the price target from $45 to $46.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 3:56 pm